Prof. Dr. med. Dieter Kabelitz
Institut für Immunologie, CAU Kiel
Born 01.01.1951

| 1971–1978 | Studies of Medicine at the Universities of Freiburg and TU Munich |
| 1979 | M.D. thesis (Dr. med., summa cum laude, TU Munich) |
| 1979–1981 | Post-Doc, Dept of Immunology, Univ. of Uppsala /Sweden (H. Wigzell) |
| 1981–1983 | Post-Doc, Rockefeller University New York (H.G. Kunkel) |
| 1983–1988 | Scientific Assistant, Dept of Microbiology & Immunology, Univ. of Ulm |
| 1985 | Habilitation in Microbiology and Immunology, Univ. of Ulm |
| 1988–1992 | C3 Professor for Cellular Immunology, Univ. of Heidelberg |
| 1992–1999 | Head, Dept. of Immunology, Paul-Ehrlich Institute Langen |
| Since 1999 | C4 Professor and Chairman of the Institute of Immunology at the Christian- Albrechts-University Kiel |
| Since 2000 | Speaker of SFB 415 |
10 Selected Publications
- Pietschmann K, Beetz S, Welte S, Martens I, Gruen J, Oberg HH, Wesch D, Kabelitz D. (2009) Toll-like receptor expression and function in subsets of human γδ T lymphocytes. Scand J Immunol 70: 245-255
- Kabelitz D, Geissler, EK, Soria B, Schroeder IF, Fändrich F, Chatenoud L. (2008) Toward cellbased therapy of type I diabetes. Trends Immunol 29: 68-74
- Paulsen M, Ussat S, Jakob M, Scherer G, Lepenies I, Schütze S, Kabelitz D, Adam-Klages S. (2008) Interaction with XIAP prevents full caspase-3/7 activation in proliferating human T lymphocytes. Eur J Immunol 38: 1979-1987
- Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grüssel S, Sipos B, Grützmann R, Pilarsky C, Ungefroren H, Saeger HD, Klöppel G, Kabelitz D, Kalthoff K. (2007) Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 67: 8344-8350
- Lettau M, Qian J, Linkermann A, Latreille M, Larose L, Kabelitz D, Janssen O. (2006) The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the immunological synapse. Proc Natl Acad Sci USA 103: 5911-5916
- Wesch D, Beetz S, Oberg HH, Marget M, Krengel K, Kabelitz D. (2006) Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ T lymphocytes. J Immunol 176: 1348-1354
- Allam A, Kabelitz D. (2006) TCR trans-rearrangements: Biological significance in antigen
recognition vs the role as lymphoma biomarker. J Immunol 176: 5707-5712 - Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. (2005) Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol 175: 2144-2151
- Kabelitz D, Pitters E, Wesch D, Zöller M. (2004) Characterization of tumor reactivity of human Vγ9Vδ2 γδ T-cells in vitro and in severe combined immunodeficiency mice in vivo. J Immunol 173: 6767-6776
- Matthews V, Schuster B, Schütze S, Bussmeyer I, Ludwig A, Hundhausen C, Sadowski T, Saftig P, Hartmann D, Kallen K-J, Rose-John S, (2003) Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J. Biol. Chem. 278: 38829-38839


